BioSpace News Archive

Cardio D iagnostics Holdings Inc (Nasdaq: CDIO) today announced it would be presenting at the Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st , 2022, at the New York Athletic Club in New York City.

Femasys Inc. today announced that the Kathy Lee-Sepsick, founder, president & chief executive officer, will present at the Piper Sandler 34th Annual Healthcare Conference being held November 29 through December 1, 2022 at the Lotte New York Palace.

Optinose today announced the pricing of an underwritten public offering of 26,320,000 shares of its common stock and warrants to purchase 26,320,000 shares of its common stock.

Blue Earth Diagnostics today announced presentations on investigational rhPSMA compounds and Axumin® (fluciclovine F 18) at the upcoming 23rd Annual Scientific Meeting in Urologic Oncology (SUO), to be held in San Diego, Calif., from November 30 to December 2, 2022.

FogPharma®, a biopharmaceutical company pioneering a new class of precision medicines that could ultimately prove applicable to the vast majority of therapeutic targets, including those previously considered “undruggable,” today announced a $178 Million Series D financing.

Dr. Keith M. Baumgarten of Orthopedic Institute is the first surgeon in South Dakota to use an innovative new solution for anterior cruciate ligament tears, recently approved by the U.S. Food and Drug Administration.

Biofrontera Inc. (Nasdaq: BFRI) announced today the launch of a randomized, double-blind, vehicle-controlled, multicenter Phase 3 clinical study to evaluate the safety and efficacy of Ameluz® and BF-RhodoLED® XL in the field-directed treatment of actinic keratosis (AK) on the extremities, neck and trunk. The study is being managed by Biofrontera Bioscience GmbH.

2San announced today that the Genabio® COVID-19 Rapid Self-Test Kit, which received FDA Emergency Use Authorization this year1, is now available on Amazon.

Vektor Medical , developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced it presented new data on its vMap ® technology that demonstrated potential utility in patients with adult congenital heart disease (ACHD).

Cryos International Sperm and Egg Bank today announced a published scientific study which suggests that the use of Virtual Reality (VR) headsets during sperm donation has a positive effect on sperm quality.